$149.26 -$2.37 (-1.6%)

04:00 PM EDT on 07/19/19

Sarepta Therapeutics Inc (NASDAQ:SRPT)

CAPS Rating: 3 out of 5

A biopharmaceutical company developing therapeutic products principally based on third-generation NEUGENE antisense technology.

Current Price $149.26 Mkt Cap $11.4B
Open $151.94 P/E Ratio 0.00
Prev. Close $151.63 Div. (Yield) $0.00 (0.0%)
Daily Range $146.33 - $151.94 Volume 639,250
52-Wk Range $103.68 - $158.80 Avg. Daily Vol. 24

Caps

How do you think NASDAQ:SRPT will perform against the market?

Add Stock to CAPS Watchlist

All Players

293 Outperform
49 Underperform
 

All-Star Players

50 Outperform
10 Underperform
 

Wall Street

13 Outperform
2 Underperform
 

Top NASDAQ:SRPT Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

Hendrickson71 (< 20)
Submitted November 20, 2015

Good volume and positive sentiment in the market = bullish for next week!

rknapton (81.42)
Submitted August 22, 2013

Short. Biopharma. Sells more stock than has revenues. Revs declining too.

NASDAQ:SRPT VS S&P 500 (SPY)

Fools bullish on NASDAQ:SRPT are also bullish on:

Fools bearish on NASDAQ:SRPT are also bearish on:

Recent Community Commentary

Read the most recent pitches from players about SRPT.

Recs

0
Member Avatar mrbill6 (< 20) Submitted: 7/12/2019 11:38:14 AM : Outperform Start Price: $155.49 NASDAQ:SRPT Score: -3.11

Heavy Favorite

Recs

0
Member Avatar nania (40.17) Submitted: 5/24/2019 11:45:59 AM : Underperform Start Price: $118.61 NASDAQ:SRPT Score: -20.68

Increasing revenue and increasing losses. Not a fan.

Recs

0
Member Avatar TMFEBCapital (93.19) Submitted: 1/28/2019 1:49:05 PM : Outperform Start Price: $117.60 NASDAQ:SRPT Score: +14.02

Potential to increase total addressable market from 13% to to 30% of Duchenne muscular dystrophy population by the end of 2020.

Leaderboard

Find the members with the highest scoring picks in SRPT.

Score Leader

Newt805

Newt805 (66.34) Score: +3,379.79

"It's one thing to feel that you're on the right path, but it's another to think that yours is the only path." Paulo Cuelho, novelist IX X XIII XIV XL XLIII

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
This player feels very strongly about this pick and has marked it a Top Pick. Top Picks do not affect a player’s score. Newt805 66.34 6/27/2012 Outperform 5Y $4.14 +3,504.27% +124.48% +3,379.79 3 Comments
ruben7086 < 20 5/10/2012 Outperform 5Y $4.80 +3,009.58% +117.48% +2,892.10 0 Comment
rustam5 75.14 4/18/2012 Outperform 5Y $5.40 +2,664.07% +113.94% +2,550.13 0 Comment
craineum 57.20 10/5/2011 Outperform 3Y $6.18 +2,315.21% +163.94% +2,151.27 0 Comment
embodiedheart < 20 4/2/2012 Outperform 5Y $6.54 +2,182.26% +109.11% +2,073.15 0 Comment
Apprentice15 95.53 2/8/2012 Outperform 3M $6.54 +2,182.26% +119.84% +2,062.42 0 Comment
blashmet < 20 2/8/2012 Outperform 5Y $6.78 +2,101.47% +120.41% +1,981.06 0 Comment
benjaeger 82.14 8/8/2011 Outperform 1Y $6.90 +2,063.19% +154.26% +1,908.93 0 Comment
Prof3215 < 20 9/16/2011 Outperform 5Y $7.50 +1,890.13% +145.07% +1,745.06 1 Comment
TheMadFlea < 20 3/22/2012 Outperform 5Y $8.16 +1,729.17% +113.57% +1,615.59 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

Player Name Player
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
S&P
Gain
Score End Date Commentary
TrackRBCCapMkts 85.64 1/22/2018 Outperform NS $63.09 +136.58% +6.10% +130.49 0 Comment
TrackJimCramer 86.23 9/30/2016 Underperform 3W $61.41 +143.05% +37.42% -105.63 0 Comment
TrackPiperJaff 86.17 8/24/2015 Outperform NS $32.00 +366.44% +58.54% +307.90 0 Comment
TrackCreditSuiss 88.09 9/24/2014 Outperform NS $21.39 +597.93% +50.10% +547.84 0 Comment
TrackCitigroup 88.20 1/6/2014 Underperform NS $19.21 +676.99% +62.02% -614.98 0 Comment
TrackStifel 91.05 9/6/2013 Outperform NS $36.87 -56.41% +18.20% -74.62 10/28/2014 @ $16.07 0 Comment
TrackCanaccord 65.71 4/9/2013 Outperform NS $36.28 +311.41% +89.94% +221.48 0 Comment
TrackRWBaird 89.54 4/4/2013 Outperform NS $34.82 +328.66% +91.24% +237.42 0 Comment
TrackDeutscheSec 82.83 3/19/2013 Outperform NS $34.60 +331.39% +91.40% +239.98 0 Comment
TrackBurrillInst < 20 11/26/2012 Outperform NS $30.15 +395.06% +111.34% +283.72 0 Comment
TrackPoisedTo < 20 10/5/2012 Outperform 5Y $36.83 +305.27% +102.33% +202.93 0 Comment
TrackZacks < 20 9/21/2012 Outperform 3M $14.47 +73.46% -5.00% +78.46 11/12/2012 @ $25.10 1 Comment
TrackJimCramer 86.23 9/21/2012 Outperform 3W $14.47 +324.40% +48.28% +276.11 9/30/2016 @ $61.41 0 Comment
TrackJMP 84.20 4/11/2012 Outperform NS $6.72 +266.82% +30.44% +236.38 1/27/2014 @ $24.65 0 Comment
TrackPoisedTo < 20 3/20/2012 Underperform 5Y $9.24 -42.27% -1.20% +41.08 4/18/2012 @ $5.33 0 Comment
TrackWedbush 88.25 4/13/2011 Outperform NS $10.38 +1,337.96% +125.05% +1,212.90 0 Comment
trackwbbsecuriti < 20 12/29/2010 Outperform NS $12.42 +1,101.77% +135.95% +965.82 0 Comment
trackthinkequity 93.16 10/21/2010 Outperform NS $12.72 +1,073.43% +151.06% +922.37 0 Comment
TrackRodmanRen < 20 8/13/2007 Outperform NS $17.34 +760.78% +113.59% +647.19 0 Comment
TrackMaximGroup 65.29 3/30/2007 Outperform NS $15.18 +883.27% +120.93% +762.34 0 Comment
TrackJimCramer 86.23 3/15/2006 Underperform 3W $41.70 -65.30% +11.60% +76.90 9/21/2012 @ $14.47 0 Comment

Advertisement